No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3ne4A_, 1.0000, 0.00, 1.000, 370, 370, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
2, d1qlpA_, 0.9970, 0.39, 1.000, 372, 370, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
3, p5nbuA_, 0.9918, 0.37, 0.978, 370, 368, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
4, d3cwlA_, 0.9917, 0.54, 1.000, 371, 369, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
5, d3cwmA_, 0.9910, 0.57, 1.000, 369, 369, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
6, d1oo8A_, 0.9908, 0.71, 0.976, 370, 370, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
7, d2qugA_, 0.9892, 0.55, 1.000, 368, 368, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
8, d1psiA_, 0.9882, 0.78, 0.997, 371, 369, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
9, p5nbvA_, 0.9788, 1.12, 0.976, 369, 368, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
10, d1ophA_, 0.9753, 1.27, 0.962, 375, 369, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
11, d3drmA_, 0.9745, 0.44, 0.997, 362, 362, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
12, p5io1A_, 0.9707, 0.86, 0.989, 365, 364, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
13, d1hp7A_, 0.9678, 1.47, 0.992, 376, 370, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
14, p5io1B_, 0.9677, 1.47, 0.992, 376, 370, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
15, p3druA_, 0.9416, 0.87, 0.986, 364, 363, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
16, p3druB_, 0.9391, 1.48, 0.986, 363, 362, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
17, p3druC_, 0.9383, 1.44, 0.989, 362, 361, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
18, d1kctA_, 0.9340, 1.35, 0.989, 360, 359, ALPHA1-ANTITRYPSIN
19, d5hgcA1, 0.9327, 2.11, 0.959, 375, 367, A SERPIN STRUCTURE
20, p3h5cA_, 0.9323, 1.84, 0.482, 368, 365, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
21, d1atuA_, 0.9315, 1.84, 0.482, 368, 365, UNCLEAVED ALPHA-1-ANTITRYPSIN
22, d4x30A_, 0.9287, 2.05, 0.334, 384, 368, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
23, d3f1sA_, 0.9265, 2.03, 0.949, 374, 369, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
24, d2hijI1, 0.9255, 1.97, 0.432, 372, 366, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
25, d1e04I_, 0.9250, 1.97, 0.432, 372, 366, PLASMA BETA ANTITHROMBIN-III
26, d1e05I_, 0.9238, 1.82, 0.331, 385, 363, PLASMA ALPHA ANTITHROMBIN-III
27, d2ceoA_, 0.9235, 1.82, 0.331, 385, 363, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
28, d2antI_, 0.9224, 2.35, 0.293, 411, 369, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
29, d2ceoB_, 0.9222, 2.40, 0.290, 403, 369, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
30, d1dzhI_, 0.9207, 2.39, 0.295, 417, 369, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
31, d1e03I_, 0.9190, 1.96, 0.440, 367, 361, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
32, d1azxI_, 0.9180, 2.41, 0.290, 419, 369, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
33, d1oyhI_, 0.9176, 1.89, 0.442, 367, 360, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
34, d1antI_, 0.9164, 2.47, 0.293, 417, 369, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
35, p4ga7A_, 0.9163, 2.48, 0.295, 418, 369, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
36, d1dzgI_, 0.9161, 2.48, 0.293, 417, 369, N135Q-S380C-ANTITHROMBIN-III
37, d1tb6I_, 0.9159, 2.51, 0.293, 416, 369, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
38, p4ga7B_, 0.9142, 2.39, 0.292, 402, 367, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
39, d2behI_, 0.9142, 1.71, 0.289, 369, 356, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
40, d1athA_, 0.9139, 2.48, 0.293, 422, 369, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
41, p4if8A_, 0.9138, 2.28, 0.298, 412, 366, STRUCTURE OF VASPIN
42, d1d5s.1, 0.9137, 1.60, 0.288, 367, 354, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
43, d1ovaB_, 0.9133, 2.44, 0.292, 413, 367, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
44, d1ovaD_, 0.9131, 2.44, 0.295, 389, 366, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
45, d1uhgB_, 0.9122, 1.82, 0.417, 367, 357, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
46, d1ovaA_, 0.9121, 1.98, 0.997, 375, 360, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
47, d1uhgD_, 0.9118, 2.10, 0.302, 371, 361, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
48, p4y3kA_, 0.9114, 2.35, 0.297, 385, 364, STRUCTURE OF VASPIN MUTANT E379S
49, d8api.1, 0.9113, 2.35, 0.297, 385, 364, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
50, p3fgqB_, 0.9110, 2.33, 0.306, 380, 363, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
51, p3fgqA_, 0.9107, 2.41, 0.305, 383, 364, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
52, d9api.1, 0.9105, 2.32, 0.303, 380, 363, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
53, d4dy7F_, 0.9099, 1.78, 0.420, 367, 355, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
54, p4y40A_, 0.9097, 1.81, 1.000, 376, 357, STRUCTURE OF VASPIN MUTANT D305C V383C
55, d7api.1, 0.9093, 2.04, 0.285, 374, 361, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
56, d2h4rA1, 0.9092, 2.05, 0.285, 374, 361, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
57, d1nq9I_, 0.9090, 2.05, 0.285, 374, 361, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
58, d2b4xI1, 0.9089, 1.82, 1.000, 375, 357, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
59, d3kcgI_, 0.9084, 2.01, 0.242, 378, 360, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
60, d4dy7C_, 0.9081, 2.01, 0.242, 378, 360, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
61, d1sr5A_, 0.9078, 1.81, 0.420, 366, 355, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
62, d1t1fC_, 0.9075, 1.84, 1.000, 375, 357, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
63, d1t1fB_, 0.9075, 1.88, 0.324, 368, 355, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
64, d1t1fA_, 0.9075, 1.88, 0.324, 368, 355, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
65, d1ezx.1, 0.9074, 2.44, 0.294, 406, 364, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
66, d4ajtA_, 0.9073, 2.43, 0.293, 413, 365, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
67, d2zv6B1, 0.9067, 2.24, 0.295, 419, 363, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
68, d1jmjB_, 0.9067, 2.04, 0.242, 377, 360, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
69, d2gd4I1, 0.9058, 2.16, 0.301, 409, 362, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
70, d1uhgA_, 0.9057, 2.01, 0.299, 419, 358, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
71, p5cdxA_, 0.9056, 2.01, 0.299, 419, 358, CRYSTAL STRUCTURE OF CONSERPIN
72, p1yxaA_, 0.9055, 2.01, 0.299, 419, 358, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
73, d2gd4C1, 0.9052, 1.88, 1.000, 371, 357, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
74, d1br8I_, 0.9048, 2.15, 0.339, 372, 360, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
75, p5ce0B_, 0.9034, 1.95, 0.336, 370, 354, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
76, d1lk6I_, 0.9031, 2.32, 0.282, 387, 365, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
77, d1jvqI_, 0.9025, 2.46, 0.301, 417, 366, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
78, d3evjI_, 0.9024, 2.39, 0.313, 378, 361, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
79, d1jmjA_, 0.9023, 1.39, 0.608, 353, 347, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
80, d1r1lI_, 0.9013, 2.30, 0.447, 372, 360, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
81, d1qmb.1, 0.9011, 2.30, 0.447, 372, 360, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
82, d1jmoA_, 0.9011, 2.42, 0.301, 418, 365, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
83, d4dy0B_, 0.9007, 2.52, 0.292, 404, 367, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
84, d1ovaC_, 0.9001, 1.43, 0.602, 353, 347, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
85, d4c41A_, 0.8996, 2.68, 0.293, 410, 369, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
86, d2ach.1, 0.8992, 2.69, 0.293, 410, 369, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
87, d1uhgC_, 0.8989, 2.46, 0.292, 404, 363, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
88, p4if8B_, 0.8985, 2.40, 0.282, 397, 365, STRUCTURE OF VASPIN
89, p5ce0A_, 0.8984, 2.71, 0.293, 416, 369, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
90, p4y40B_, 0.8975, 1.96, 0.992, 368, 356, STRUCTURE OF VASPIN MUTANT D305C V383C
91, d1as4.1, 0.8974, 2.35, 0.280, 425, 364, CLEAVED ANTICHYMOTRYPSIN A349R
92, d5ncsA1, 0.8969, 2.35, 0.280, 425, 364, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
93, d5ncsB1, 0.8963, 1.98, 0.236, 370, 356, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
94, p4y3kB_, 0.8963, 2.21, 0.303, 373, 356, STRUCTURE OF VASPIN MUTANT E379S
95, d1sekA_, 0.8949, 2.01, 0.445, 367, 355, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
96, d4c49A_, 0.8948, 2.01, 0.445, 367, 355, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
97, p1yxaB_, 0.8948, 1.95, 0.472, 372, 356, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
98, p2dutD_, 0.8947, 2.25, 0.306, 370, 356, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
99, p2dutC_, 0.8947, 1.79, 0.414, 361, 350, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
100, p2dutB_, 0.8947, 1.43, 0.612, 352, 345, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
101, p2dutA_, 0.8947, 1.75, 0.415, 361, 349, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
102, d1xqgB1, 0.8940, 1.91, 0.475, 369, 354, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
103, d3pb1I_, 0.8919, 2.25, 0.251, 370, 359, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
104, d1xqgA1, 0.8918, 2.25, 0.251, 370, 359, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
105, d1xqjA1, 0.8912, 2.25, 0.251, 370, 359, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
106, p2ol2A_, 0.8909, 1.77, 0.415, 361, 349, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
107, p3f5nD_, 0.8908, 2.51, 0.286, 376, 360, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
108, p3f5nA_, 0.8908, 1.97, 0.446, 367, 354, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
109, p3vvjB_, 0.8907, 2.22, 0.447, 368, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
110, p3vvjC_, 0.8905, 2.24, 0.309, 366, 356, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
111, d2vdxA_, 0.8904, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
112, d3le2A1, 0.8898, 2.24, 0.309, 366, 356, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
113, d1db2A_, 0.8890, 2.24, 0.309, 366, 356, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
114, p3vvjA_, 0.8886, 2.26, 0.256, 375, 360, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
115, d1attB_, 0.8886, 2.51, 0.291, 375, 364, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
116, p6cj7A_, 0.8878, 2.29, 0.258, 375, 360, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
117, d4c49B_, 0.8878, 2.29, 0.258, 375, 360, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
118, d2b5tI_, 0.8873, 2.30, 0.258, 375, 360, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
119, d3r4lA_, 0.8870, 2.11, 0.467, 360, 353, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
120, d4caa.1, 0.8868, 2.11, 0.467, 360, 353, CLEAVED ANTICHYMOTRYPSIN T345R
121, d5du3A_, 0.8867, 2.12, 0.296, 363, 355, ACTIVE FORM OF HUMAN C1-INHIBITOR
122, p2hi9A_, 0.8863, 2.26, 0.295, 364, 356, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
123, d5brrI_, 0.8861, 2.28, 0.289, 384, 357, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
124, d4c49C_, 0.8855, 2.20, 0.289, 384, 356, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
125, d2vdxB_, 0.8854, 2.00, 0.442, 366, 353, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
126, d4dteA_, 0.8853, 2.36, 0.238, 391, 361, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
127, d1i99I_, 0.8852, 2.36, 0.238, 391, 361,  
128, d2zv6A_, 0.8851, 2.65, 0.294, 377, 364, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
129, d1attA_, 0.8850, 2.32, 0.289, 384, 357, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
130, d5du3B_, 0.8849, 2.24, 0.300, 410, 357, ACTIVE FORM OF HUMAN C1-INHIBITOR
131, d1k9oI_, 0.8848, 1.80, 0.282, 357, 348, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
132, d3caa.1, 0.8839, 1.87, 0.450, 362, 349, CLEAVED ANTICHYMOTRYPSIN A347R
133, d1xu8B1, 0.8837, 2.41, 0.299, 415, 358, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
134, p3f5nB_, 0.8827, 2.81, 0.293, 377, 365, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
135, d2zv6C1, 0.8824, 1.93, 0.476, 366, 351, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
136, p2hi9B_, 0.8824, 2.04, 0.267, 378, 352, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
137, p5ei0A_, 0.8821, 2.04, 0.267, 378, 352, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
138, d4eb1I_, 0.8821, 2.32, 0.463, 356, 354, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
139, p3b9fI_, 0.8816, 2.70, 0.295, 372, 363, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
140, d1imvA_, 0.8816, 1.90, 0.447, 363, 349, 2.85 A CRYSTAL STRUCTURE OF PEDF
141, d2vdyB_, 0.8812, 1.80, 0.447, 360, 347, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
142, d4dteB_, 0.8810, 2.57, 0.253, 374, 363, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
143, d5duqA_, 0.8809, 2.57, 0.253, 374, 363, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
144, d1oc0A_, 0.8809, 2.74, 0.286, 376, 360, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
145, d3q03A_, 0.8806, 2.74, 0.286, 376, 360, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
146, p5ei0E_, 0.8805, 1.62, 0.341, 350, 343, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
147, d3ozqA1, 0.8804, 2.16, 0.299, 420, 354, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
148, d3pzfA_, 0.8800, 2.10, 0.264, 377, 352, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
149, d4dy0A_, 0.8798, 2.75, 0.286, 376, 360, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
150, d5duqB_, 0.8795, 1.97, 0.471, 366, 350, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
151, p2hi9C_, 0.8771, 2.45, 0.251, 372, 358, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
152, d2vdyA_, 0.8770, 2.08, 0.296, 366, 351, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
153, d3ut3C_, 0.8766, 1.62, 0.345, 349, 342, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
154, p2r9yA_, 0.8764, 2.16, 0.462, 354, 351, STRUCTURE OF ANTIPLASMIN
155, d1b3kC_, 0.8762, 2.13, 0.424, 372, 354, PLASMINOGEN ACTIVATOR INHIBITOR-1
156, d1b3kA_, 0.8761, 2.13, 0.424, 372, 354, PLASMINOGEN ACTIVATOR INHIBITOR-1
157, d1dvmA_, 0.8755, 3.01, 0.290, 411, 366, ACTIVE FORM OF HUMAN PAI-1
158, d1dvmD_, 0.8749, 2.09, 0.466, 356, 350, ACTIVE FORM OF HUMAN PAI-1
159, d1dvmB_, 0.8749, 2.22, 0.282, 375, 355, ACTIVE FORM OF HUMAN PAI-1
160, d4roaA_, 0.8746, 2.22, 0.282, 375, 355, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
161, d1xu8A1, 0.8740, 1.98, 0.443, 361, 348, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
162, d1jtiA_, 0.8740, 2.29, 0.259, 364, 355, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
163, d1jtiB_, 0.8739, 2.09, 0.269, 362, 350, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
164, p2ol2B_, 0.8735, 2.34, 0.301, 364, 355, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
165, d3ut3A_, 0.8732, 2.03, 0.298, 360, 349, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
166, d3q02A_, 0.8731, 2.10, 0.425, 371, 353, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
167, d1dvmC_, 0.8724, 2.18, 0.282, 361, 351, ACTIVE FORM OF HUMAN PAI-1
168, p3f5nC_, 0.8721, 2.18, 0.282, 361, 351, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
169, d1by7A_, 0.8719, 2.47, 0.213, 369, 356, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
170, d4zk0A_, 0.8717, 2.47, 0.213, 369, 356, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
171, d4g8rB1, 0.8716, 2.04, 0.246, 362, 349, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
172, d1hle.1, 0.8715, 2.12, 0.271, 365, 350, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
173, d4g8oD1, 0.8714, 1.95, 0.475, 346, 345, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
174, d4g8oC1, 0.8708, 2.05, 0.443, 361, 348, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
175, d3ndaA_, 0.8705, 2.40, 0.299, 368, 354, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
176, d3ndaB_, 0.8702, 1.97, 0.277, 365, 347, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
177, d4zk3A_, 0.8694, 1.97, 0.277, 365, 347, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
178, d1db2B_, 0.8694, 2.51, 0.301, 373, 356, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
179, d4ic0C_, 0.8692, 2.51, 0.301, 373, 356, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
180, d4ic0A_, 0.8690, 2.47, 0.299, 375, 355, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
181, d4c49D_, 0.8688, 2.42, 0.297, 372, 354, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
182, d2peeA_, 0.8687, 2.36, 0.299, 365, 354, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
183, d3ut3D_, 0.8683, 2.49, 0.215, 364, 354, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
184, d2peeB_, 0.8682, 2.21, 0.254, 364, 351, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
185, d3ut3B_, 0.8680, 2.27, 0.299, 381, 351, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
186, d3q03B_, 0.8678, 2.27, 0.299, 381, 351, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
187, d1b3kD_, 0.8669, 1.87, 0.478, 343, 343, PLASMINOGEN ACTIVATOR INHIBITOR-1
188, d1b3kB_, 0.8669, 2.42, 0.300, 367, 353, PLASMINOGEN ACTIVATOR INHIBITOR-1
189, d1wz9B_, 0.8667, 2.15, 0.298, 358, 349, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
190, d4p0oA_, 0.8650, 2.45, 0.291, 364, 354, CLEAVED SERPIN 42DA
191, d3q02B_, 0.8650, 2.42, 0.287, 358, 348, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
192, d2arqA_, 0.8643, 1.90, 0.321, 354, 343, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
193, d1lq8.1, 0.8637, 2.15, 0.335, 367, 349, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
194, d4g8oA1, 0.8635, 2.40, 0.298, 367, 352, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
195, d4g8oB1, 0.8634, 2.12, 0.324, 375, 349, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
196, d4ic0D_, 0.8633, 2.12, 0.324, 375, 349, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
197, d2arrA_, 0.8632, 2.41, 0.301, 366, 352, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
198, d1lq8.4, 0.8631, 2.42, 0.301, 366, 352, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
199, d3dlwA_, 0.8628, 2.33, 0.303, 374, 353, ANTICHYMOTRYPSIN
200, d4ic0B_, 0.8627, 2.33, 0.303, 374, 353, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
201, d1lq8.2, 0.8625, 2.23, 0.305, 372, 351, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
202, d4g8rA_, 0.8621, 2.16, 0.342, 366, 348, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
203, d4robB_, 0.8616, 2.29, 0.303, 362, 350, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
204, d4rsqK_, 0.8610, 2.44, 0.298, 366, 352, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
205, d2behL_, 0.8608, 2.43, 0.293, 366, 352, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
206, d4rsqL_, 0.8605, 1.92, 0.443, 356, 343, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
207, d2b4xL_, 0.8604, 2.59, 0.242, 387, 355, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
208, d2antL_, 0.8595, 2.59, 0.242, 387, 355, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
209, d3evjL_, 0.8594, 2.30, 0.303, 360, 350, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
210, d1lq8.3, 0.8594, 2.73, 0.242, 387, 356, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
211, d1r1lL_, 0.8593, 2.30, 0.303, 360, 350, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
212, d4rsqG_, 0.8589, 2.30, 0.294, 364, 350, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
213, d1e05L_, 0.8589, 2.29, 0.304, 358, 349, PLASMA ALPHA ANTITHROMBIN-III
214, d1e04L_, 0.8589, 2.29, 0.304, 358, 349, PLASMA BETA ANTITHROMBIN-III
215, d4rsqB_, 0.8588, 2.25, 0.273, 355, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
216, d1jvqL_, 0.8587, 2.35, 0.309, 371, 350, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
217, d1lk6L_, 0.8586, 2.35, 0.309, 371, 350, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
218, d4rsqE_, 0.8584, 2.25, 0.296, 362, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
219, d4rsqH_, 0.8583, 2.41, 0.311, 360, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
220, d1br8L_, 0.8583, 2.41, 0.311, 360, 351, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
221, d2hijL_, 0.8582, 2.08, 0.468, 358, 344, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
222, d1jrrA_, 0.8579, 2.30, 0.296, 358, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
223, d4rsqI_, 0.8578, 2.30, 0.296, 358, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
224, d4rsqF_, 0.8577, 2.31, 0.296, 359, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
225, p3zhaD_, 0.8577, 2.44, 0.311, 358, 351, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
226, d1iz2A_, 0.8574, 2.14, 0.468, 359, 344, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
227, d1dzhL_, 0.8574, 2.29, 0.461, 360, 345, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
228, d4rsqJ_, 0.8568, 2.32, 0.299, 358, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
229, d4robA_, 0.8568, 2.03, 0.469, 357, 343, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
230, d1oyhL_, 0.8568, 2.32, 0.302, 357, 348, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
231, d1e03L_, 0.8566, 2.58, 0.214, 356, 350, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
232, d4rsqD_, 0.8565, 2.56, 0.209, 356, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
233, d1nq9L_, 0.8564, 2.31, 0.308, 403, 347, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
234, d1dzgL_, 0.8564, 2.57, 0.209, 356, 349, N135Q-S380C-ANTITHROMBIN-III
235, d1azxL_, 0.8564, 2.37, 0.307, 410, 348, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
236, d4rsqA_, 0.8563, 2.39, 0.307, 398, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
237, d1antL_, 0.8562, 2.39, 0.305, 417, 348, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
238, d4rsqC_, 0.8553, 2.16, 0.480, 357, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
239, d1a7cA_, 0.8543, 2.39, 0.307, 409, 348, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
240, d1wz9A_, 0.8535, 2.73, 0.211, 357, 351, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
241, d1qmnA_, 0.8528, 2.39, 0.307, 417, 348, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
242, d4eb1L_, 0.8526, 2.34, 0.308, 412, 347, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
243, p3zhaA_, 0.8515, 2.59, 0.210, 355, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
244, p3zhaB_, 0.8514, 2.40, 0.307, 406, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
245, p3zhaC_, 0.8510, 2.40, 0.305, 406, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
246, d4robC_, 0.8497, 2.61, 0.209, 356, 349, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
247, d4ro9A_, 0.8490, 2.80, 0.211, 357, 351, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
248, p5c98B_, 0.8482, 2.42, 0.307, 398, 348, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
249, p3f5nE_, 0.8476, 2.36, 0.305, 409, 347, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
250, p5cdzA_, 0.8455, 2.44, 0.309, 357, 349, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
251, d3cvmA_, 0.8455, 2.71, 0.212, 356, 349, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
252, p4au4C_, 0.8448, 2.50, 0.210, 353, 347, CRYSTAL STRUCTURE OF HSP47
253, p5c98A_, 0.8447, 2.76, 0.285, 368, 358, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
254, d4ro9B_, 0.8445, 2.53, 0.974, 371, 350, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
255, d3cvmB_, 0.8445, 2.37, 0.308, 407, 347, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
256, d2v95A_, 0.8435, 2.65, 0.206, 355, 349, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
257, d2v6dA_, 0.8435, 2.63, 0.215, 356, 349,  
258, d1sngA1, 0.8435, 2.38, 0.308, 410, 347, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
259, p3zhaP_, 0.8433, 2.43, 0.305, 423, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
260, d4p0fA_, 0.8416, 2.43, 0.305, 423, 348, CLEAVED SERPIN 42DA (C 2 2 21)
261, p3zhaQ_, 0.8411, 2.74, 0.209, 355, 350, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
262, p3zhaL_, 0.8406, 2.34, 0.309, 413, 346, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
263, d3eoxA_, 0.8401, 2.39, 0.308, 409, 347, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
264, p3zhaK_, 0.8391, 2.43, 0.302, 414, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
265, p4au4G_, 0.8388, 2.65, 0.210, 356, 348, CRYSTAL STRUCTURE OF HSP47
266, p4au4F_, 0.8383, 2.37, 0.308, 392, 347, CRYSTAL STRUCTURE OF HSP47
267, p2wy0C_, 0.8374, 2.76, 0.209, 354, 349, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
268, p2wxyC_, 0.8369, 2.52, 0.302, 364, 351, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
269, p4au2A_, 0.8360, 2.27, 0.256, 357, 344, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
270, p4au4E_, 0.8351, 2.59, 0.458, 365, 347, CRYSTAL STRUCTURE OF HSP47
271, p4au4D_, 0.8341, 2.38, 0.310, 392, 345, CRYSTAL STRUCTURE OF HSP47
272, p4au2D_, 0.8328, 2.88, 0.284, 380, 359, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
273, p4au3D_, 0.8319, 2.88, 0.284, 380, 359, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
274, d1athB_, 0.8303, 2.70, 0.291, 364, 354, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
275, p4au4B_, 0.8294, 2.93, 0.283, 376, 360, CRYSTAL STRUCTURE OF HSP47
276, p4au4A_, 0.8290, 2.57, 0.214, 351, 345, CRYSTAL STRUCTURE OF HSP47
277, p4au2B_, 0.8285, 2.60, 0.214, 353, 346, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
278, p4yiaA_, 0.8284, 2.81, 0.187, 364, 353, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
279, p2xn6A_, 0.8273, 2.81, 0.187, 364, 353, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
280, d3stoA_, 0.8267, 2.05, 0.298, 340, 336, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
281, p2riwA_, 0.8264, 2.33, 0.612, 361, 340, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
282, p2xn3A_, 0.8260, 2.58, 0.298, 377, 349, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
283, p2xn5A_, 0.8258, 2.94, 0.288, 370, 358, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
284, p2xn7A_, 0.8254, 2.56, 0.191, 359, 346, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
285, d4aqhA1, 0.8249, 2.51, 0.216, 348, 342, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
286, p2rivA_, 0.8243, 2.59, 0.298, 377, 349, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
287, p3nddA_, 0.8220, 2.25, 0.413, 342, 339, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
288, d4aqhC1, 0.8219, 2.25, 0.413, 342, 339, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
289, p5m3yA_, 0.8216, 2.23, 0.236, 345, 335, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
290, d4aqhB1, 0.8215, 2.99, 0.284, 373, 359, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
291, d1mtp.1, 0.8215, 2.35, 0.308, 369, 341, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
292, d4ro9C_, 0.8207, 2.92, 0.289, 365, 356, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
293, p4r9iA_, 0.8202, 2.96, 0.286, 369, 357, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
294, p2wxzA_, 0.8202, 2.55, 0.298, 370, 346, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
295, p2wxxC_, 0.8197, 3.05, 0.284, 374, 359, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
296, p2wxwA_, 0.8196, 2.98, 0.287, 368, 356, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
297, d2d26A1, 0.8194, 2.97, 0.287, 368, 356, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
298, p3t1pA_, 0.8189, 2.91, 0.199, 424, 351, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
299, p3ndfA_, 0.8183, 2.92, 0.199, 419, 351, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
300, p2x0bH_, 0.8182, 2.95, 0.290, 367, 355, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
301, p2x0bF_, 0.8182, 3.00, 0.290, 367, 355, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
302, p2x0bD_, 0.8182, 2.98, 0.291, 366, 354, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
303, p2x0bB_, 0.8182, 2.78, 0.290, 359, 348, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
304, p4au3B_, 0.8165, 2.87, 0.283, 359, 350, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
305, p2wxxD_, 0.8157, 2.24, 0.317, 362, 334, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
306, p2wxxB_, 0.8156, 3.10, 0.287, 368, 356, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
307, d3lw2A_, 0.8140, 3.04, 0.288, 366, 354, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
308, p2wxxA_, 0.8138, 2.77, 0.292, 354, 346, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
309, p4au3C_, 0.8119, 1.98, 0.437, 337, 325, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
310, p4au3A_, 0.8101, 1.99, 0.437, 337, 325, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
311, d2pefA_, 0.8083, 2.87, 0.235, 361, 344, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
312, d1c5gA_, 0.8071, 2.87, 0.235, 361, 344, PLASMINOGEN ACTIVATOR INHIBITOR-1
313, d4kdsA_, 0.8065, 2.01, 0.437, 337, 325, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
314, p2wxzC_, 0.8051, 2.01, 0.437, 337, 325, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
315, d2oayA1, 0.8050, 2.01, 0.437, 341, 325, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
316, p2wy1B_, 0.8032, 2.02, 0.437, 339, 325, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
317, p2wy1A_, 0.8032, 2.79, 0.302, 379, 344, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
318, d1dvnA_, 0.7996, 2.04, 0.437, 339, 325, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
319, p4au2C_, 0.7961, 2.09, 0.988, 335, 325, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
320, d1lj5A_, 0.7960, 2.82, 0.302, 379, 344, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
321, p4ajuA_, 0.7952, 3.11, 0.211, 418, 350, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
322, d2vh4A_, 0.7912, 2.82, 0.305, 379, 344, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
323, p3dy0A_, 0.7893, 2.52, 0.242, 355, 335, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
324, p5ncwA_, 0.7858, 2.52, 0.242, 355, 335, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
325, p5m3xB_, 0.7811, 2.39, 0.221, 336, 330, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
326, d2vh4B_, 0.7806, 3.05, 0.172, 378, 348, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
327, d1c8o.1, 0.7802, 3.05, 0.172, 378, 348, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
328, p5m3xA_, 0.7770, 3.33, 0.213, 422, 356, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
329, p5ncuA_, 0.7755, 3.17, 0.205, 422, 351, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
330, p5nctA_, 0.7713, 3.12, 0.209, 438, 350, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
331, d2znhB_, 0.7710, 3.12, 0.209, 438, 350, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
332, d2znhA_, 0.7664, 2.13, 0.972, 336, 325, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
333, d9paiA_, 0.7608, 2.10, 0.982, 340, 325, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
334, d1f0c.1, 0.7607, 2.14, 0.988, 336, 325, STRUCTURE OF THE VIRAL SERPIN CRMA
335, d1m93.1, 0.7527, 3.12, 0.209, 409, 350, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
336, p4pywA1, 0.7498, 3.12, 0.209, 409, 350, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
337, d1jjo.2, 0.7392, 3.12, 0.209, 408, 350, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
338, d1jjo.1, 0.7392, 3.12, 0.209, 409, 350, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
339, p4bb2A1, 0.6345, 2.81, 0.283, 351, 343, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
340, p5om7A1, 0.5930, 3.15, 0.200, 411, 350, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
341, p5om2A1, 0.5926, 3.14, 0.202, 428, 351, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
342, p5om6A1, 0.5921, 2.64, 0.289, 365, 336, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
343, p5om8A1, 0.5917, 3.18, 0.203, 412, 350, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
344, p5om5A1, 0.5915, 3.13, 0.284, 357, 349, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
345, p5om3A1, 0.5868, 3.03, 0.280, 354, 346, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
346, p4afxA1, 0.5861, 2.80, 0.249, 366, 337, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
347, p2h4pA1, 0.5829, 3.11, 0.302, 379, 344, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
348, p2h4qA1, 0.5814, 3.11, 0.302, 379, 344, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
349, p6ftpA1, 0.5751, 2.97, 0.268, 370, 339, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
350, p5om6C1, 0.5749, 3.23, 0.222, 413, 347, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
351, p3f02B1, 0.5552, 2.58, 0.274, 366, 329, CLEAVED HUMAN NEUROSERPIN
352, p3f02A1, 0.5434, 3.27, 0.213, 417, 348, CLEAVED HUMAN NEUROSERPIN
